Nilotinib is effective in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blastic phase. (Q33398675)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Nilotinib is effective in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blastic phase. |
scientific article |
Statements
Nilotinib is effective in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blastic phase (English)
F J Giles
H M Kantarjian
P D le Coutre
M Baccarani
F-X Mahon
R E Blakesley
N J Gallagher
K Gillis
13 December 2011